Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
Department of Pediatrics, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
Sci Rep. 2020 Jan 29;10(1):1413. doi: 10.1038/s41598-020-58101-8.
A substantial portion of Mendelian disease patients suffers from genetic variants that are inherited in a recessive manner. A precise understanding of pathogenic recessive variants in a population would assist in pre-screening births of such patients. However, a systematic understanding of the contribution of recessive variants to Mendelian diseases is still lacking. Therefore, genetic diagnosis and variant discovery of 553 undiagnosed Korean patients with complex neurodevelopmental problems (KND for Korean NeuroDevelopmental cohort) were performed using whole exome sequencing of patients and their parents. Disease-causing variants, including newly discovered variants, were identified in 57.5% of the probands of the KND cohort. Among the patients with the previous reported pathogenic variants, 35.1% inherited these variants in a recessive manner. Genes that cause recessive disorders in our cohort tend to be less constrained by loss-of-function variants and were enriched in lipid metabolism and mitochondrial functions. This observation was applied to an estimation that approximately 1 in 17 healthy Korean individuals carry at least one of these pathogenic variants that develop severe neurodevelopmental problems in a recessive manner. Furthermore, the feasibility of these genes for carrier screening was evaluated. Our results will serve as a foundation for recessive variant screening to reduce occurrences of rare Mendelian disease patients. Additionally, our results highlight the utility and necessity of whole exome sequencing-based diagnostics for improving patient care in a country with a centralized medical system.
大量孟德尔疾病患者的遗传变异是隐性遗传的。对人群中致病隐性变异的精确理解将有助于对这些患者的出生进行预筛查。然而,对隐性变异对孟德尔疾病的贡献仍缺乏系统的理解。因此,对 553 名患有复杂神经发育问题的未确诊韩国患者(KND 为韩国神经发育队列)进行了全外显子组测序,以进行遗传诊断和变异发现,包括患者及其父母。在 KND 队列的 57.5%的先证者中发现了致病变异,包括新发现的变异。在先前报道的致病性变异的患者中,35.1%以隐性方式遗传这些变异。我们队列中导致隐性疾病的基因较少受到功能丧失变异的限制,并且富含脂质代谢和线粒体功能。这一观察结果适用于以下估计:大约每 17 个健康的韩国个体中就有一个至少携带一个这些致病性变异,这些变异以隐性方式导致严重的神经发育问题。此外,还评估了这些基因进行携带者筛查的可行性。我们的研究结果将为隐性变异筛查提供基础,以减少罕见孟德尔疾病患者的发生。此外,我们的研究结果强调了基于全外显子组测序的诊断在集中医疗体系国家改善患者护理的实用性和必要性。